Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update
Go back to Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update| US BioTec Inc New Common Shares (NASDAQ: SBC) | Delayed: 3.07 +0.12 (4.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.95 | 52 Week High | $0.40 | |||
| Open | $2.91 | 52 Week Low | $0.40 | |||
| Day High | $3.13 | P/E | N/A | |||
| Day Low | $2.91 | EPS | $0.00 | |||
| Volume | 82,563 | |||||
